Cyclomune 0.05% Sterile Eye Drop
Prescription required
Coupons & Offers
Easy Refunds
Fast Delivery
Highlights
composition with strength
Ciclosporin (0.05%w/v)
description
It is used to treat dry eyes by reducing inflammation n the eye.
key benefits
Dry eyes
side effects
Burning sensation in eye
how to use
For external use only Use this medication in the recommended dose and duration Refer to the label for instructions and carefully place the drops into the lower eyelid without contact
alcohol interaction
Safe
pregnancy interaction
Consult Your Doctor
lactation interaction
Unsafe
driving interaction
Consult Your Doctor
kidney interaction
Caution
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Drogheria Sellers Private Limited
Seller Address
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
Pharmacy License No.
MH-TZ1-581061, MH-TZ1-581062
Manufacturer Name
Sun Pharmaceutical Industries Limited
Manufacturer Address
90, Delhi - Jaipur Road, Sector 32, Gurugram, Haryana 122001
Country of Origin
India
Shelf Life
24 months
Expires on or after
August 2026
